MedTrace Logo

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

NCT03178929 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2017-06-07

No results posted yet for this study

Summary

The aim of this study is to explore the effect of SAMe on recurrence after radical treatment of Primary liver cancer.

Conditions

  • Primary Liver Cancer

Interventions

DRUG

S-Adenosyl Methionine

2000mg, po

Sponsors & Collaborators

  • Beijing Insight Science & Technology Co. Ltd.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2020-07-01
Completion
2020-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178929 on ClinicalTrials.gov